01463nam 2200421 450 991070496750332120131118105056.0(CKB)5470000002446069(OCoLC)863154300(EXLCZ)99547000000244606920131118d2013 ua 0engurmn|||||||||rdacontentrdamediardacarrierElectronic drug labeling no consensus on the advantages and disadvantages of its exclusive use : report to congressional committees[Washington, D.C.] :United States Government Accountability Office,2013.1 online resource (ii, 20 pages)Title from title screen (viewed Nov. 7, 2013)."July 2013.""GAO-13-592."Includes bibliographical references.Electronic drug labeling DrugsLabelingGovernment policyUnited StatesElectronic recordsGovernment policyUnited StatesPublic healthUnited StatesPharmaceutical industryUnited StatesDrugsLabelingGovernment policyElectronic recordsGovernment policyPublic healthPharmaceutical industryGPOGPOBOOK9910704967503321Electronic drug labeling3522150UNINA